Ironwood Pharmaceuticals (IRWD) Current Assets (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Current Assets across 17 years of filings, most recently posting $199.2 million for Q2 2026.

• In Q2 2026, Current Assets rose 3.88% year-over-year to $199.2 million; the TTM figure through Jun 2026 stood at $199.2 million (up 3.88% YoY), while the FY2025 annual figure was $274.2 million, up 50.34% from the prior year.
• Current Assets came in at $199.2 million for Q2 2026 at Ironwood Pharmaceuticals, down from $332.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $866.4 million in Q1 2023 to a low of $160.6 million in Q1 2025.
• Average Current Assets over 5 years is $369.9 million, with a median of $263.7 million recorded in 2023.
• Year-over-year, Current Assets sank 75.97% in 2024 and surged 106.93% in 2026.
• Over 5 years, Current Assets stood at $780.6 million in 2022, then tumbled by 70.12% to $233.3 million in 2023, then retreated by 21.83% to $182.4 million in 2024, then jumped by 50.34% to $274.2 million in 2025, then decreased by 27.35% to $199.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $199.2 million in Q2 2026, $332.3 million in Q1 2026, and $274.2 million in Q4 2025.